Investing.com - Financial Markets Worldwide

Eone Diagnomics Genome Center Co Ltd (245620)

KOSDAQ
Currency in KRW
415
0(0.00%)
Closed·
245620 Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
Trading near 52-week High
Fair Value
Unlock Value
Day's Range
401435
52 wk Range
401435
Key Statistics
Edit
Bid/Ask
415.00 / 420.00
Prev. Close
415
Open
432
Day's Range
401-435
52 wk Range
401-435
Volume
-
Average Volume (3m)
1.62M
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
245620 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 12
Stock generally trades with low price volatility
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Eone Diagnomics Genome Center Co Ltd Company Profile

Eone Diagnomics Genome Center Co., Ltd. provides genetic information analysis services in South Korea. It engages in the genome research and development, genomic testing/screening, IT, and software activities. The company offers NICE, a non-invasive prenatal test, which detects a fetal DNA in maternal plasma for the pregnancy period; bebegene Plus, a newborn genetic screening test that analyzes base sequence and early screening genetic diseases; RiskCARE, which detects the risk of hereditary cancer early to prevent cancer; BRCARE, a genetic test in BRCA1 and BRCA2 genes for hereditary breast/ovarian cancer; genocube, a cancer and general disease prediction test; and Liquid Biopsy, a non-invasive alternative to tissue biopsy that helps to determine cancer treatments by identifying clinically relevant biomarkers. It also provides MYGENPLAN, which suggests personalized health care guide by analyzing personal genetic risks and current health status; TELOAGE that suggests personal genetic risk of diseases and personalized nutrition guide by analyzing current status of telomere; and gene2me Plus, which analyzes genes based on single nucleotide polymorphism array chip and predicts cancers and other diseases, as well as MyEyeGene, a genetic test for inherited eye diseases. Eone Diagnomics Genome Center Co., Ltd. was founded in 2013 and is based in Incheon, South Korea.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
59
Market
South Korea

Compare 245620 to Peers and Sector

Metrics to compare
245620
Peers
Sector
Relationship
P/E Ratio
−1.5x−4.2x−0.5x
PEG Ratio
−0.040.130.00
Price/Book
20.8x1.4x2.6x
Price / LTM Sales
2.2x3.2x3.2x
Upside (Analyst Target)
-18.0%41.7%
Fair Value Upside
Unlock1.4%6.1%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-3.79 / --
Revenue / Forecast
4.91B / --
EPS Revisions
a
a
Unlock
Last 90 days

245620 Income Statement

FAQ

What Stock Exchange Does Eone Diagnomics Genome Trade On?

Eone Diagnomics Genome is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Eone Diagnomics Genome?

The stock symbol for Eone Diagnomics Genome is "245620."

What Is the Eone Diagnomics Genome Market Cap?

As of today, Eone Diagnomics Genome market cap is 57.44B.

What Is Eone Diagnomics Genome's Earnings Per Share (TTM)?

The Eone Diagnomics Genome EPS (TTM) is -268.77.

From a Technical Analysis Perspective, Is 245620 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Eone Diagnomics Genome Stock Split?

Eone Diagnomics Genome has split 1 times.

How Many Employees Does Eone Diagnomics Genome Have?

Eone Diagnomics Genome has 59 employees.

What is the current trading status of Eone Diagnomics Genome (245620)?

As of 26 Jul 2025, Eone Diagnomics Genome (245620) is trading at a price of 415.00, with a previous close of 415.00. The stock has fluctuated within a day range of 401.00 to 435.00, while its 52-week range spans from 401.00 to 435.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.